Skip to main content
OpenTrials

Clinical trial condition

Type 2 Diabetes Mellitus

Explore clinical trials studying Type 2 Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

1,509 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Type 2 Diabetes Mellitus trial results

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period

NCT02787551

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 8400064 Birmingham, Alabama, United States
  • Investigational Site Number 8400073 Fountain Hills, Arizona, United States
  • Investigational Site Number 8400047 Phoenix, Arizona, United States
  • Investigational Site Number 8400103 Bakersfield, California, United States
View all 124 locations
View Trial Details
Completed

A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus

NCT02973321

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 8400028 Sheffield, Alabama, United States
  • Investigational Site Number 8400002 Huntington Park, California, United States
  • Investigational Site Number 8400024 Los Angeles, California, United States
  • Investigational Site Number 8400001 Los Angeles, California, United States
View all 59 locations
View Trial Details
Completed

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy

NCT01499095

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 840517 Birmingham, Alabama, United States
  • Investigational Site Number 840149 Chandler, Arizona, United States
  • Investigational Site Number 840093 Glendale, Arizona, United States
  • Investigational Site Number 840069 Phoenix, Arizona, United States
View all 213 locations
View Trial Details

Related conditions